Checkmate Therapeutics

체크메이트테라퓨틱스

Seoul, South Korea · Founded 2019

Headquarters
Seoul
Employees
1–10
Founded
2019
Business Model
B2B

About

Checkmate Therapeutics is a Seoul-based biopharmaceutical company founded in 2019 focused on discovering and developing first-in-class therapies for metastatic and difficult-to-treat cancers. The company employs novel target-based drug discovery approaches to identify innovative therapeutics for patients suffering from cancer and other incurable diseases. Founded by Professor Hyun Seok Kim of Yonsei University College of Medicine, who serves as Founder and CSO, the company bridges academic oncology research with translational drug development. Checkmate Therapeutics operates at the early stage of the drug discovery pipeline with a focus on targeted cancer therapies.

Summary

Checkmate Therapeutics is a Biotech company based in Seoul, South Korea, founded in 2019.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Checkmate Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/checkmate-therapeutics"><img src="https://indexed.vc/api/badge/company/checkmate-therapeutics" alt="Checkmate Therapeutics on Indexed.vc" width="260" height="76" /></a>